埋线针灸治疗腰椎间盘突出症的多中心随机对照试验方案
本研究为多中心、随机、患者评估者盲法、假埋线对照、平行对照临床试验方案。拟纳入70例19-70岁、下腰痛VAS>40mm的腰椎间盘突出症患者,随机分入埋线组与假埋线组,每周治疗1次共8周,主要结局为8周后下腰痛VAS变化,以评估埋线针灸的疗效与安全性。
要点
- 拟纳入70例下腰痛VAS>40mm的腰椎间盘突出症患者。
- 埋线组与假埋线组每周治疗1次,共8周,取23个预设穴位。
- 主要结局为8周后下腰痛100mm VAS变化。
核心结论
- 该试验结果将有助于建立埋线针灸治疗腰椎间盘突出症患者的临床证据。
研究设计与样本
- 多中心、随机、患者评估者盲法、假埋线对照、两平行臂临床试验方案。
- 拟招募70例19-70岁、下腰痛100mm VAS评分大于40mm的腰椎间盘突出症患者。
- 患者随机分配至埋线针灸组和假埋线针灸组。
关键数值与推荐
- 两组均接受23个预设穴位治疗,每周1次,共8周。
- 假埋线组使用去除线体的针具,埋线组采用常规埋线针灸。
- 主要结局为8周后下腰痛100mm VAS变化。
- 次要结局包括放射痛100mm VAS、Oswestry功能障碍指数、Roland-Morris残疾问卷、EuroQol五维五水平量表及总体感知效应。
- 所有结局在基线及筛查后4、8、12、16周评估。
临床怎么用
- 该方案为埋线针灸治疗腰椎间盘突出症提供严格设计的随机对照试验框架。
局限性
- 原文指出既往相关研究质量较低,埋线针灸在此方面的临床证据较少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A lumbar herniated intervertebral disc (LHIVD) is a common problem that usually causes lower back pain and neurological symptoms that manifest as radiating pain. Several studies have reported that thread-embedding acupuncture (TEA) is effective in the treatment of LHIVD. However, these studies were of low quality and there is therefore little clinical evidence for the effectiveness of TEA in this regard. The aim of the present study is to establish the clinical evidence regarding the efficacy and safety of TEA in the treatment of pain, function, and quality of life in patients with LHIVD. The study uses a rigorously designed, full-scale, randomized clinical trial (RCT) protocol. METHOD/DESIGN: This is a multicenter, randomized, patient-assessor blinded, sham-controlled trial with two parallel arms. Seventy patients with LHIVD who have lower back pain more severe than 40 mm on the 100-mm visual analogue scale (VAS), and who are aged 19-70 years, will be recruited and randomly allocated to a TEA group and sham TEA (STEA) group. Both groups will receive treatment on 23 predefined acupoints once a week for eight weeks; needles with the thread removed will be used in the STEA group, while normal TEA will be employed in the TEA group. Changes in the 100-mm VAS for lower back pain after eight weeks will be assessed as the primary outcome. Furthermore, the 100-mm VAS for radiating pain, Oswestry Disability Index, Roland-Morris disability questionnaire, EuroQol 5 Dimensions 5 Levels, and global perceived effect will be measured and analyzed as secondary outcomes. All outcomes will be assessed at baseline and at 4, 8, 12, and 16 weeks after screening. DISCUSSION: The results of this trial will help to establish the clinical evidence regarding TEA in the treatment of patients with LHIVD. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03236753 . Registered on August 2, 2017. Clinical Research Information Service of the Republic of Korea, KCT0002439 . Registered on August 1, 2017.
引用
- Goo B, Ryoo DW, Kim EJ, et al. Clinical research on the efficacy and safety of thread-embedding acupuncture for treatment of herniated intervertebral disc of the lumbar spine: a protocol for a multicenter, randomized, patient-assessor blinded, controlled, parallel, clinical trial. Trials. 2018. PMID: 30201029. doi:10.1186/s13063-018-2864-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。